早期VV-ECMO可在因ANCA相关的血管炎引起的严重扩散膜出血时提供免疫抑制疗法
Ye Ji Jung1, Sunjin Ryu2, Young Kim3
1Division of Rheumatology, Department of Internal Medicine, Cheonan Chungmu Hospital, Cheonan, Republic of Korea.
Respiratory medicine case reports
|March 9, 2026
概括
这一案例研究表明,毒性ECMO可以将患有严重ANCA相关血管炎 (AAV) 扩散膜出血 (DAH) 的患者与免疫抑制联系起来. 早期的环胺改善了结果,避免了透析.
科学领域:
- 肺部病理学 肺部病理学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
背景情况:
- 扩散膜出血 (DAH) 是ANCA相关血管炎 (AAV) 的严重并发症.
- 针对AAV-DAH的最佳治疗顺序,特别是ECMO期间有活跃出血的情况,由于抗凝血需要,具有挑战性.
- 这一案例突出了患有 fulminant AAV-DAH 需要体外膜氧化 (ECMO) 的患者的管理.
研究的目的:
- 通过使用毒性ECMO成功管理严重的AAV-DAH的案例.
- 评估在活跃肺部出血中ECMO期间最小化抗凝剂的安全性和有效性.
- 强调早期免疫抑制治疗在AAV-DAH中的重要性.
主要方法:
- 一名62岁的患有血栓塞和低氧血症的妇女接受了有毒ECMO治疗,其抗凝固作用降到最低.
- 高剂量的甲基prednisolone和静脉循环胺被管理.
- 通过氧化,功能和炎症标志物监测治疗反应.
主要成果:
- 患者的氧化得到改善,允许在11天内停止ECMO治疗,并在3周内进行输出管.
- 尽管最初的严重损伤,功能在没有透析的情况下得到改善.
- 在ECMO与最小化的抗凝血治疗期间,没有发生血栓并发症.
结论:
- 带有个性化抗凝剂的有毒ECMO可以作为严重AAV-DAH中免疫抑制的关键桥梁.
- 早期服用环胺对于限制多器官损伤和可能防止需要置换疗法的必要性至关重要.
相关概念视频
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
578
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
578
Myocarditis III: Medical Management
286
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
286
Endocarditis III: Medical Management
296
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
296
Pericarditis III: Medical Management
452
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
452


